KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Work In Process (2016 - 2022)

Bio-Rad Laboratories (BIO) has disclosed Work In Process for 14 consecutive years, with $158.8 million as the latest value for Q2 2022.

  • On a quarterly basis, Work In Process rose 6.88% to $158.8 million in Q2 2022 year-over-year; TTM through Jun 2022 was $158.8 million, a 6.88% increase, with the full-year FY2021 number at $142.7 million, down 6.05% from a year prior.
  • Work In Process was $158.8 million for Q2 2022 at Bio-Rad Laboratories, up from $153.2 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $158.8 million in Q2 2022 to a low of $140.9 million in Q2 2018.
  • A 5-year average of $148.4 million and a median of $148.9 million in 2018 define the central range for Work In Process.
  • Peak YoY movement for Work In Process: grew 12.89% in 2018, then fell 8.17% in 2021.
  • Bio-Rad Laboratories' Work In Process stood at $145.1 million in 2018, then grew by 0.74% to $146.1 million in 2019, then rose by 3.97% to $151.9 million in 2020, then fell by 6.05% to $142.7 million in 2021, then increased by 11.25% to $158.8 million in 2022.
  • Per Business Quant, the three most recent readings for BIO's Work In Process are $158.8 million (Q2 2022), $153.2 million (Q1 2022), and $142.7 million (Q4 2021).